Novel anti-pad2 antibody
AssigneePharma Foods International Co., Ltd.
InventorsKenji SAITO, Tomoko SAKATA, Takaaki KAWANOBE, Keita KOGA
Life of this patent
Estimating the term…
Abstract
To obtain an anti-PAD2 antibody having excellent PAD2 inhibitory activity. Provided is an anti-PAD2 antibody that specifically binds to positions 341 to 357 of PAD2. Also provided is an anti-PAD2 antibody that specifically binds to a peptide consisting of an amino acid sequence set forth in SEQ ID NO: 1.
Claims13
1-16. (canceled)
A method for treating rheumatoid arthritis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-PAD2 antibody, wherein the anti-PAD2 antibody specifically binds to a calcium-bound human PAD2 and inhibits citrullination activity of the calcium-bound human PAD2, and wherein a KD (M) of the anti-PAD2 antibody toward human PAD2 is 9.0×10−8 or less.
Dependencies are inferred from the claim text.